Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5529_Библиотеки_им_академика_М_И_Перельмана
.pdf
154 Bioinformatics of Autoimmune Diseases
enzymes, or receptors that play key roles in disease mechanisms. In the context of autoimmune diseases, drug targets often include cytokines, immune receptors, kinases, or transcription factors that
regulate inammation and immune response. The JSON structure organizes targets hierarchically,
listing the primary target name followed by more detailed information related to that interaction.
This structured approach ensures that researchers can easily analyze which specic molecules are
affected by a drug and how they contribute to disease progression or remission.
The drug details encompass additional information associated with each drug, including its
name, KEGG Drug ID, and relevant molecular interactions. The drug _ name eld stores the
recognized name of the drug, while the drug _ id provides a unique KEGG ID that links to the
KEGG database, enabling further exploration. One particularly valuable component of the drug
details is LigandBox (Figure 4.9), which is a part of KEGG that provides molecular structure data,
including three-dimensional conformations and physicochemical properties of drugs. LigandBox
information is essential for computational modeling, virtual screening, and docking studies, allowing researchers to predict drug–target interactions at the molecular level. In the JSON output, if
available, LigandBox details may appear within the target hierarchy, giving additional insights into
the structural properties of the drug that inuence binding afnity and specicity.
By including these detailed drug–target interactions along with LigandBox data, the JSON output serves as a powerful resource for researchers studying autoimmune diseases. It allows for a
deeper understanding of how drugs interact with biological systems, supports drug repurposing
efforts, and aids in computational drug discovery. This structured format enables researchers to
FIGURE 4.9 LigandBox in JSON output. It provides 3D structure of the drug.
155 Bioinformatics Databases
efciently compare multiple drugs, identify novel therapeutic targets, and integrate computational
modeling approaches with experimental data to enhance autoimmune disease treatment strategies.
4.2.3.5 Retrieving Enzymes and Pathways in Autoimmune Disease
The enzymes involved in autoimmune disease pathways play a crucial role in regulating immune
responses, inammation, and tissue remodeling. Many of these enzymes belong to the hydrolase,
transferase, or oxidoreductase classes, each with specic functions in cellular metabolism. For
example, matrix metalloproteinases (MMPs) such as MMP-1 (EC 3.4.24.7) are involved in the degradation of extracellular matrix components, which is a critical process in diseases like rheumatoid
arthritis, where excessive tissue breakdown leads to joint damage. Another important enzyme group
includes serine proteases like trypsin (EC 3.4.21.4), which participate in inammatory processes
and immune regulation. By identifying these enzymes, researchers can better understand disease
mechanisms and develop targeted therapies to modulate their activity.
The Enzyme Commission (EC) numbering system is a hierarchical classication method for
enzymes based on the reactions they catalyze. The EC number consists of four levels, denoted as
x.y.z.w, where the rst number represents the main enzyme class (such as hydrolases or transferases), the second describes the subclass (such as peptide bond hydrolysis), and subsequent numbers
specify more rened reaction details. This system allows for standardized identication and comparison of enzymes across different biological pathways. In autoimmune diseases, EC classication
helps researchers pinpoint specic enzymes involved in immune signaling, antigen processing, and
inammatory pathways. By analyzing enzyme activity and interactions within pathways, scientists
can identify potential drug targets to modulate immune responses.
The Python program “kegg _ enzymes _ disease.py” retrieves enzyme and metabolic
pathway information related to a given autoimmune disease using the KEGG API. The script rst
searches for the disease, extracts associated pathways, and then identies genes and their corresponding enzymes. The results, including pathway IDs, gene names, and enzyme EC numbers along
with their names, are saved in both JSON and TSV formats (Figure 4.10). This structured output
provides an easy-to-use dataset for further computational analysis or integration into research studies. The TSV le ensures compatibility with spreadsheet software for quick visualization, while the
JSON le is well-suited for programmatic data processing.
This tool is highly benecial for researchers studying autoimmune diseases, as it automates the
retrieval of key molecular components involved in disease mechanisms. By identifying enzymes
linked to specic pathways, scientists can explore their roles in disease progression and therapeutic intervention. Moreover, this approach facilitates the discovery of novel biomarkers and drug
targets by highlighting key metabolic and signaling enzymes involved in autoimmune conditions.
Researchers can use the data to develop computational models, perform comparative pathway analysis, and design experiments for enzyme inhibition or activation studies. The ability to quickly
extract and analyze disease-related enzymatic data signicantly accelerates biomedical research,
ultimately contributing to better diagnostic and treatment strategies.
FIGURE 4.10 The enzymes involved in rheumatoid arthritis pathway.
156 Bioinformatics of Autoimmune Diseases
4.2.3.6 Retrieving Autoimmune Disease PPIs via KEGG and STRING
Protein–protein interactions (PPIs) are fundamental to cellular function, playing a crucial role in
signal transduction, immune responses, and disease mechanisms. In the context of autoimmune
diseases, understanding PPIs is essential for identifying key molecular players involved in immune
dysregulation. The KEGG database provides detailed pathway maps that illustrate how proteins
interact in various biological processes, including immune signaling and inammation. By analyzing these interactions, researchers can gain insights into disease mechanisms, identify biomarkers, and develop targeted therapies. Autoimmune diseases are characterized by aberrant immune
responses that often involve complex networks of interacting proteins. Mapping these networks
through KEGG pathways allows researchers to dissect how genetic and environmental factors contribute to disease progression, ultimately leading to more effective therapeutic strategies.
The Python script “kegg _ ppi _ disease.py” automates the retrieval and analysis of PPIs
associated with autoimmune diseases by integrating KEGG and STRING databases. It begins by
identifying KEGG pathways related to the specied disease and extracts associated genes. These
gene IDs are then converted into STRING-compatible formats, allowing the retrieval of known
and predicted PPIs. By leveraging these databases, the script ensures that researchers have access
to high-quality interaction data without the need for manual queries. The nal output is structured
into CSV and JSON formats, making it easily accessible for further computational analysis. This
automation signicantly streamlines the data collection process, reducing errors and enhancing
reproducibility in research.
The structured dataset generated by the script serves as a valuable resource for researchers studying autoimmune diseases. By analyzing the retrieved PPIs, scientists can uncover potential regulatory hubs, investigate protein interaction networks, and explore new therapeutic targets. The CSV
format facilitates integration with spreadsheet tools for manual inspection, while the JSON format
supports computational workows and machine learning applications (Figure 4.11). This dataset
FIGURE 4.11 The PPIs associated with rheumatoid arthritis pathway.
157 Bioinformatics Databases
can be further used for network analysis, pathway enrichment studies, and visualization in bioinformatics tools. Ultimately, this approach enhances our understanding of autoimmune disease
mechanisms, paving the way for novel treatment strategies and precision medicine.
For example, the Python program “p pi _ network.py ” visualizes a PPI network from a CSV
le containing protein pairs. Using the pandas library, it rst reads the CSV le into a DataFrame,
where each row represents an interaction between two proteins. It then constructs an undirected
graph using networkx, adding each protein as a node and each interaction as an edge. For visualization, the script employs matplotlib and the force-directed spring_layout to position the nodes
in a visually intuitive way. Nodes are drawn in sky blue with increased size for clarity, while edges
are rendered with moderate thickness. Protein names are labeled with an enlarged, bold font for
better readability, and the overall graph is displayed with a clear, descriptive title. This program provides a clear and informative visualization of molecular interactions, facilitating biological insight
into the relationships among the involved proteins (Figure 4.12).
A PPI network is a graphical representation of the physical or functional associations between
proteins within a cell or biological system. In this network, nodes represent individual proteins,
while edges (connections) denote interactions between them, which may involve direct binding,
participation in the same signaling pathway, or co-regulation of cellular processes. Interpreting a
FIGURE 4.12 Protein–protein interaction network associated with rheumatoid arthritis.
158 Bioinformatics of Autoimmune Diseases
PPI network involves analyzing its topological structure to identify key proteins, often referred to
as hubs, that interact with many others and may play central roles in cellular function or disease.
Clusters or modules within the network often correspond to protein complexes or biological pathways, revealing insights into the molecular mechanisms underlying specic conditions. By integrating biological knowledge with computational network analysis, researchers can prioritize candidate
biomarkers, identify therapeutic targets, and better understand the functional organization of the
proteome.
The PPI network shown in Figure 4.12 provides a molecular snapshot of functional relation-
ships relevant to rheumatoid arthritis. Central to the network are key immune-related proteins such
as IL10, IL6, CIITA, PTPN22, and HLA-DRB1, which are highly connected and act as interaction hubs. These hubs suggest a convergence of inammatory and immune-regulatory pathways,
reecting the complex immunopathogenesis of rheumatoid arthritis. For example, IL10 and IL6
are cytokines involved in modulating inammation, while PTPN22 and HLA-DRB1 are known
genetic risk factors implicated in T-cell signaling and antigen presentation, respectively. The interactions involving NFKBIL1 and IRF5 further highlight the activation of transcriptional responses
driving chronic inammation. Clustering patterns around PTPN22, IL10, and HLA-DRB1 suggest
tight coordination between signaling, cytokine response, and antigen processing mechanisms, reinforcing their role in autoimmune dysregulation. Overall, this network underscores the interplay of
innate and adaptive immune components in rheumatoid arthritis and may aid in identifying potential therapeutic targets or biomarkers.
4.2.3.7 Regulatory Genes and Transcription Factors in Autoimmune Pathways
KEGG provides a valuable repository of genes involved in various biological pathways, including those linked to autoimmune diseases. Autoimmune diseases arise from dysregulated immune
responses, often inuenced by specic genetic factors that modulate immune function. In KEGG,
genes involved in regulation play critical roles in immune signaling, inammation, and immune
tolerance. For instance, in diseases like rheumatoid arthritis and SLE, key regulatory genes such as
TNF, IL6, STAT3, FOXP3, PTPN22, and RELA contribute to disease progression by controlling
inammatory cytokines and immune cell differentiation. These genes often interact with complex
immune networks, where mutations or aberrant expression can lead to chronic inammation and
self-reactivity. Their regulatory functions extend to T-cell activation, cytokine signaling, and antigen presentation, all of which are crucial in maintaining immune homeostasis. By understanding
how these genes operate, researchers can identify potential therapeutic targets and develop personalized treatments for autoimmune conditions.
Transcription factors are proteins that regulate gene expression by binding to specic DNA
sequences and modulating transcription. In autoimmune diseases, transcription factors like STAT3,
FOXP3, NF-κB, and IRF5 are particularly signicant due to their roles in controlling immune cell
activation and inammatory responses. STAT3, for example, is essential in the JAK–STAT signaling pathway, which regulates cytokine-mediated immune responses. FOXP3 is a master regulator of
regulatory T cells (Tregs), crucial for maintaining immune tolerance and preventing autoimmunity.
Mutations or dysfunction in FOXP3 can lead to uncontrolled immune activation and autoimmunity.
NF-κB is a key player in inammatory pathways, inuencing the production of pro-inammatory
cytokines and survival of immune cells. IRF5 is another transcription factor strongly associated
with autoimmune diseases, as it regulates type I interferon responses, which are often hyperactive
in lupus and other conditions. Understanding how these transcription factors function and interact
with regulatory genes can reveal new intervention strategies to modulate immune responses and
reduce disease severity.
The Python script “kegg _ reg _ and _ TFs.py” retrieves KEGG pathways associated
with a specic autoimmune disease and extracts genes involved in regulation and transcription
factors. By allowing user input, the script searches KEGG for relevant pathways, extracts NCBI
gene IDs linked to those pathways, and identies transcription factors based on keyword matching.
159 Bioinformatics Databases
The results are stored in two separate text les, one for genes and another for transcription factors,
ensuring organized data storage for further analysis. This automation simplies the process of identifying key molecular players in autoimmune diseases, making it an efcient tool for researchers.
The output provides a list of genes and transcription factors specic to the disease, offering insights
into molecular mechanisms that drive autoimmunity.
Next, the extracted gene and transcription factor data can be leveraged for various applications
in autoimmune disease research. Gene expression analysis can be conducted using RNA-Seq or
microarray datasets to validate the involvement of these genes in diseased versus healthy individuals. Functional enrichment analysis can help identify biological pathways where these genes and
transcription factors are most active. Computational modeling and machine learning approaches
could predict disease progression based on gene expression patterns. Additionally, potential drug
targets could be identied by analyzing interactions between these transcription factors and smallmolecule inhibitors. With the rise of CRISPR-based genome editing, targeted gene modications
could be explored to correct dysregulated genes in autoimmune diseases. Integrating KEGG data
with patient-specic genetic proles could lead to personalized medicine strategies, enabling tailored treatments that target individual genetic susceptibilities. This script serves as a foundational
tool that, when combined with experimental and computational approaches, can advance our understanding of autoimmune diseases and facilitate the development of innovative therapies.
4.2.3.8 Retrieving Autoimmune Disease Risk Factors
Genetic risk factors play a critical role in the development of autoimmune diseases, inuencing
susceptibility and severity. These factors include genetic variants and polymorphisms, which are
alterations in DNA sequences that may affect gene function. In KEGG, genetic variants and polymorphisms are linked to pathways associated with various diseases, including autoimmune disorders. These genetic variations can lead to abnormal immune responses, triggering an attack on the
body’s own tissues. The presence of specic polymorphisms in immune-related genes can alter the
regulation of cytokines, antigen presentation, and immune signaling, contributing to disease onset
and progression. Understanding these genetic variations allows researchers to identify potential
biomarkers for disease prediction and personalized therapeutic interventions.
In the context of autoimmune diseases, KEGG provides a structured representation of genes
and their associated variants that contribute to immune dysfunction. Genes such as HLA-DRB1,
IL6, and PTPN22 are frequently implicated in autoimmune pathogenesis. Variants within these
genes can disrupt immune homeostasis, leading to chronic inammation and tissue damage. For
example, polymorphisms in the HLA-DRB1 gene have been strongly associated with rheumatoid
arthritis, inuencing antigen presentation and immune response modulation. Similarly, IL6 variants
may enhance pro-inammatory cytokine production, exacerbating conditions like lupus. By mapping these genetic alterations to KEGG pathways, researchers can trace their impact on molecular mechanisms, shedding light on how genetic predispositions translate into autoimmune disease
manifestations.
The Python program “kegg _ risk _ factor _ ids.py” developed for this study automates
the retrieval of genetic risk factors related to autoimmune diseases by interfacing with KEGG,
ClinVar, GWAS Catalog, and Ensembl databases. By inputting the name of an autoimmune disease,
the program identies associated genes and retrieves known genetic variants. The results are saved
in a structured CSV le, where each gene is listed alongside its corresponding variants, separated
by a delimiter for easy reference. This automation streamlines the process of genetic data collection,
allowing researchers to quickly obtain relevant information without manually searching multiple
databases.
The program’s output is particularly valuable for further investigation into autoimmune diseases.
By compiling gene-variant associations, researchers can analyze trends in genetic susceptibility
across populations, validate ndings with experimental studies, and explore potential therapeutic
targets. The integration of multiple databases enhances data reliability, ensuring that the retrieved
160 Bioinformatics of Autoimmune Diseases
variants are well-supported by existing genetic research. Future applications of this program could
involve expanding the analysis to include additional omics data, such as transcriptomics and proteomics, to provide a more comprehensive view of autoimmune disease mechanisms. Ultimately,
this tool aids in advancing personalized medicine approaches by pinpointing genetic factors that
may inform targeted treatment strategies for autoimmune conditions.
4.2.4 ADEX
ADEX (Autoimmune Diseases Explorer) is a specialized bioinformatics database that compiles
and organizes gene expression data related to autoimmune diseases. Its portal at https://adex.genyo.
es/ serves as a valuable resource for researchers studying the molecular mechanisms underlying
conditions. By integrating transcriptomic data from various high-throughput experiments, including RNA-Seq and microarray analyses, ADEX provides insights into differentially expressed genes
associated with autoimmune pathophysiology. This information is critical for identifying potential
biomarkers, understanding disease progression, and developing targeted therapies. The database is
structured to allow users to explore gene expression patterns across different diseases, tissues, and
experimental conditions, providing a comprehensive view of immune dysregulation at the transcriptomic level.
To search ADEX, users typically begin by entering specic queries such as a gene name, a disease of interest, or a biological pathway. The database’s search functionality enables ltering results
based on experimental conditions, tissue types, or study methodologies, ensuring that researchers
can access the most relevant data for their investigations. The retrieved results often include gene
expression levels presented in various formats, such as fold change values, statistical signicance
markers, and visualization tools like heatmaps or scatter plots. These visual representations help
researchers quickly identify genes that are upregulated or downregulated in autoimmune conditions, facilitating hypothesis generation and experimental validation.
ADEX also supports programmatic access, allowing researchers to retrieve large datasets for
computational analysis. Through API services or downloadable data les, scientists can integrate
ADEX data with other bioinformatics tools for further exploration, such as gene network analysis,
pathway enrichment studies, and machine learning–based biomarker discovery. The ability to compare expression proles across multiple autoimmune diseases enhances the understanding of shared
and distinct molecular signatures, aiding in the development of personalized treatment approaches.
By providing well-curated and high-quality gene expression data, ADEX plays a crucial role in
advancing autoimmune disease research and fostering the discovery of novel therapeutic targets.
4.2.5 IAAA
The Interactive Analysis and Atlas for Autoimmune disease (IAAA) is a comprehensive bioinformatics resource dedicated to the collection and organization of information on autoantibodies
associated with autoimmune diseases (http://galaxy.ustc.edu.cn/IAAA). Autoantibodies are key
biomarkers in autoimmune pathology, often serving as diagnostic indicators and playing signicant roles in disease progression. The IAAA database compiles detailed records of autoantibodies
detected in various autoimmune disorders. It provides essential details such as the specic autoantibodies present in a given disease, their target antigens, associated clinical manifestations, and their
diagnostic relevance. This information is critical for researchers investigating the immunological
basis of autoimmunity, as well as for clinicians seeking reliable markers for disease diagnosis and
prognosis.
To search the IAAA database, users can enter keywords related to a specic autoimmune disease, an autoantibody name, or a target antigen. The database provides structured query options
that allow ltering based on disease type, autoantibody class (such as IgG or IgM), and experimental validation methods. Search results typically include tables or lists displaying the autoantibody
161 Bioinformatics Databases
name, its corresponding antigen, disease associations, and references to scientic literature where
the ndings were reported. Some entries include additional experimental details, such as the detection method used (e.g., ELISA, Western blot, or immunoprecipitation) and prevalence statistics
within patient populations. By enabling systematic searches, the IAAA database facilitates the
identication of potential biomarkers and helps researchers establish links between autoimmune
responses and specic molecular targets.
The data retrieved from IAAA can be used in various ways, depending on the research or clinical application. In autoimmune disease research, scientists utilize the database to explore patterns
of autoantibody production and to understand their role in disease mechanisms. For instance, by
analyzing the occurrence of autoantibodies in different diseases, researchers can identify shared
immunological pathways that might contribute to multiple autoimmune conditions. This is particularly useful for studying polyautoimmunity, where patients exhibit more than one autoimmune
disorder. Clinicians use IAAA to verify known autoantibodies in disease diagnosis and to identify
potential novel markers for early detection or disease monitoring. The database also supports computational research by allowing programmatic access to data, which can be used in machine learning models to predict autoantibody-disease associations or in network analysis to study immune
system interactions.
By providing a structured and easily accessible repository of autoantibody-related data, IAAA
serves as a valuable tool for both experimental and clinical research. The integration of autoantibody proles with genetic, proteomic, and immunological data enhances our understanding of
autoimmune diseases, potentially leading to improved diagnostic assays and therapeutic strategies.
The ability to query, retrieve, and analyze autoantibody-related information in a centralized manner
accelerates autoimmune research and contributes to the broader eld of immunology.
4.2.6 DISGENET
DisGeNET (https://disgenet.com/) is a comprehensive knowledge platform that integrates informa-
tion on gene–disease associations from multiple sources, including curated databases, scientic
literature, and GWAS. It is widely used in biomedical research to explore the genetic underpinnings
of various diseases, including autoimmune disorders. By consolidating disparate data sources into
a single, harmonized framework, DisGeNET provides researchers with an extensive collection of
genetic associations that help in understanding disease mechanisms, identifying potential biomarkers, and discovering novel therapeutic targets. The database includes information on both common
and rare genetic variants linked to diseases, offering insights into how genetic predisposition contributes to disease susceptibility and progression.
Searching DisGeNET can be done through its web interface or programmatically via its REST
API. The web interface allows users to enter a disease name, gene symbol, or variant ID in the
search bar to retrieve relevant associations. Results are presented with an evidence score that quanties the strength of the association based on data from different sources. Users can lter results
based on the origin of the data, such as expert-curated sources, text-mining from scientic articles,
or GWAS datasets. Additionally, the platform offers advanced search features that enable researchers to explore disease networks, co-occurring genes, and functional annotations related to specic
disorders. The interactive visualization tools provide network graphs that illustrate the relationships
between genes and diseases, allowing users to identify key genetic players in autoimmunity.
The retrieved data from DisGeNET can be used in a variety of bioinformatics analyses.
Researchers studying autoimmune diseases often download gene–disease association datasets for
integration with other omics data, such as transcriptomics or proteomics, to identify differentially
expressed genes or pathways involved in disease progression. The information from DisGeNET is
also utilized in systems biology approaches to construct disease interaction networks, helping to
uncover common genetic factors between different autoimmune conditions. Additionally, pharmaceutical researchers use DisGeNET to prioritize drug targets by identifying genes strongly associated
162 Bioinformatics of Autoimmune Diseases
with disease phenotypes. The API access allows bioinformaticians to integrate DisGeNET data into
their pipelines for large-scale computational analyses, making it a valuable resource for both experimental and computational autoimmune disease research.
4.3 SUMMARY
Bioinformatics databases are essential in the study of autoimmune diseases, providing extensive
repositories of genetic, proteomic, transcriptomic, epigenetic, and functional data. These resources
support researchers in identifying disease-associated variants, analyzing gene expression, exploring regulatory elements, and understanding molecular pathways contributing to immune system
dysfunction. With the integration of high-throughput sequencing technologies, bioinformatics has
signicantly advanced the understanding of autoimmune disorders, paving the way for precision
medicine tailored to individual genetic proles.
Several major bioinformatics databases are crucial in autoimmune disease research. The NCBI
GenBank is a foundational resource offering a vast collection of nucleotide sequences across different organisms, aiding comparative genomic studies to identify disease-related genetic variations.
dbSNP is another essential resource, cataloging genetic variations across populations, helping in
identifying SNPs associated with autoimmune conditions. Ensembl provides detailed genomic
annotations and integrates GWAS data, while the GEO serves as a repository for gene expression
data from microarrays and RNA-Seq experiments. Specialized transcriptomic databases like the
SRA and Expression Atlas facilitate the study of immune system dysregulation through alternative
splicing and regulatory RNA analysis.
Other databases focus on the genetic and clinical aspects of diseases. The OMIM database provides curated information on genetic disorders, including autoimmune diseases, although its focus
on monogenic conditions limits its applicability to complex disorders. The dbGaP offers largescale genetic and clinical data to explore genotype–phenotype relationships. Proteomic databases
like UniProt provide detailed information on protein sequences, interactions, and functional annotations, which are critical in understanding immune system dysfunction at the molecular level.
Additionally, specialized resources like the ADEX and the IAAA offer transcriptomic and methylation study integration, enhancing data analysis in autoimmune research.
NCBI Entrez is a central hub for biological databases, linking genetic, proteomic, and clinical
information. It allows researchers to query multiple databases simultaneously, retrieving records
on genetic sequences, protein structures, scientic literature, and disease-related data. Entrez
integrates with various databases such as GenBank for nucleotide sequences, dbSNP for genetic
variations, GEO for gene expression proles, and ClinVar for clinically relevant genetic variants.
Additionally, Entrez provides access to protein-related databases, including UniProt, PDB, and the
Structure database, which offer insights into protein sequences and 3D structures relevant to autoimmune diseases.
To facilitate automated data retrieval, NCBI provides E-utilities, a set of API tools allowing
researchers to access and extract data programmatically. These utilities support various output
formats, including XML, JSON, FASTA, and GenBank formats, depending on the nature of the
data being retrieved. For instance, XML and JSON formats are useful for structured data parsing, whereas FASTA is commonly used for sequence-based analyses. Researchers can leverage
these utilities with Biopython and other programming tools to automate tasks such as retrieving
gene sequences, fetching transcript and protein data, and analyzing genetic variants in autoimmune
diseases.
Beyond genomics, the UniProt database is instrumental in protein research, offering extensive
annotations on protein function, interactions, PTMs, and structural details. The database integrates
information on disease-associated proteins, linking them to specic pathways and cellular processes. Using the UniProt API, researchers can retrieve protein sequences and associated metadata
in JSON format, enabling efcient computational analysis. The Ensembl REST API complements
163 Bioinformatics Databases
this by providing genomic and variant data, supporting researchers in mapping genes to their corresponding protein products and functional annotations.
Through the use of automated scripts and computational tools, researchers can systematically
explore bioinformatics databases to extract meaningful insights into autoimmune diseases. By integrating genomic, transcriptomic, and proteomic data, scientists can identify genetic risk factors,
study disease mechanisms, and develop targeted therapeutic strategies. The renement of bioinformatics methodologies continues to enhance the understanding of autoimmune disorders, driving
advancements in personalized medicine and therapeutic interventions.
BIBLIOGRAPHY
Amberger, J. S., Bocchini, C. A., Scott, A. F., & Hamosh, A. (2019). OMIM.org: Leveraging knowledge across
phenotype–gene relationships. Nucleic Acids Research, 47(D1), D1038–D1043. https://doi.org/10.1093/
nar/gky1151
Martorell-Marugán, J., Toro-Domínguez, D., Fernández-Anta, A., de la Fuente, A., & Carmona-Sáez, P.
(2021). A comprehensive database for integrated analysis of omics data in autoimmune diseases (ADEx).
Database, 2021, baab043. https://doi.org/10.1093/database/baab043
Benson, D. A., Karsch-Mizrachi, I., Lipman, D. J., Ostell, J., & Sayers, E. W. (2013). GenBank. Nucleic Acids
Research, 41(D1), D36–D42. https://doi.org/10.1093/nar/gks1195
Clough, E., & Barrett, T. (2016). The Gene Expression Omnibus database. Methods in Molecular Biology,
1418, 93–110. https://doi.org/10.1007/978-1-4939-3578-9_5
Cunningham, F., Achuthan, P., Akanni, W., Allen, J., Amode, M. R., Armean, I. M., et al. (2019). Ensembl
2019. Nucleic Acids Research, 47(D1), D745–D751. https://doi.org/10.1093/nar/gky1113
Karczewski, K. J., & Snyder, M. P. (2018). Integrative omics for health and disease. Nature Reviews Genetics,
19(5), 299–310. https://doi.org/10.1038/nrg.2018.4
Leinonen, R., Sugawara, H., & Shumway, M. (2011). The Sequence Read Archive. Nucleic Acids Research,
39(Suppl 1), D19–D21. https://doi.org/10.1093/nar/gkq1019
Pratyush, P., Carrier, C., Pokharel, S., Ismail, H. D., Chaudhari, M., & KC, D. B. (2025). CaLMPhosKAN:
Prediction of general phosphorylation sites in proteins via fusion of codon aware embeddings with amino
acid aware embeddings and wavelet-based Kolmogorov-Arnold network. Bioinformatics, 41(4), btaf124.
https://doi.org/10.1093/bioinformatics/btaf124
Sherry, S. T., Ward, M.-H., Kholodov, M., Baker, J., Phan, L., Smigielski, E. M., & Sirotkin, K. (2001).
dbSNP: The NCBI database of genetic variation. Nucleic Acids Research, 29(1), 308–311. https://doi.
org/10.1093/nar/29.1.308
Sudmant, P. H., Mallick, S., Nelson, B. J., Swaminathan, S., Nilsen, G. B., Rogers, E. M., et al. (2015). An
integrated map of structural variation in 2,504 human genomes. Nature, 526(7571), 75–81. https://doi.
org/10.1038/nature15394
The UniProt Consortium. (2021). UniProt: The universal protein knowledgebase in 2021. Nucleic Acids
Research, 49(D1), D480–D489. https://doi.org/10.1093/nar/gkaa1100
Tryka, K. A., Hao, L., Sturcke, A., Jin, Y., Wang, Z. Y., Ziyabari, L., et al. (2014). NCBI’s Database of
Genotypes and Phenotypes: dbGaP. Nucleic Acids Research, 42(Database issue), D975–D979. https://
doi.org/10.1093/nar/gkt1211
Uhlen, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., et al. (2015). Proteomics.
Tissue-based map of the human proteome. Science, 347(6220), 1260419. https://doi.org/10.1126/
science.1260419
Shen, Z., Fang, M., Sun, W., Tang, M., Liu, N., Zhu, L., et al. (2022). Interactive Analysis and Atlas for
Autoimmune Diseases (IAAA). Database, 2022, baac050. https://doi.org/10.1093/database/baac050
Соседние файлы в папке Библиотека им академика М.И. Перельмана